Tenax Therapeutics (TENX) Assets Average (2011 - 2026)
Tenax Therapeutics (TENX) posted quarterly Assets Average of $122.4 million for Q2 2026, up 12.36% year-over-year from $109.0 million in Q2 2025, and up 7.67% on a QoQ basis from $113.7 million in Q1 2026.
Tenax Therapeutics (TENX) Assets Average (2011 - 2026) Analysis & Trends
Tenax Therapeutics has reported Assets Average for 14 years, with the latest figure at $122.4 million in Q2 2026.
- Assets Average for Q2 2026 came in at $122.4 million, up 12.36% year-over-year; the trailing twelve-month figure through Jun 2026 was $122.4 million (up 12.36% YoY), and the FY2025 annual result was $100.5 million, up 85.39% from the prior year.
- Assets Average improved to $122.4 million in Q2 2026, from $113.7 million in the prior quarter.
- Over five years, Assets Average peaked at $122.4 million in Q2 2026 and troughed at $4.1 million in Q4 2022.
- A 5-year average of $50.4 million and a median of $13.9 million in 2023 frame the typical range for Assets Average.
- The widest annual swing landed in 2022, when Assets Average sank 45.36%; it then jumped 768.98% in 2025.
- A 5-year view of Assets Average shows it stood at $4.1 million in 2022, then soared by 189.47% to $11.8 million in 2023, then jumped by 733.42% to $98.2 million in 2024, then gained by 5.38% to $103.5 million in 2025, then gained by 18.26% to $122.4 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $122.4 million in Q2 2026, $113.7 million in Q1 2026, and $103.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Tenax Therapeutics | 80.73 Mn | 80.73 Mn | - | 122.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.42 Mn |
| Mar 31, 2026 | 113.70 Mn |
| Dec 31, 2025 | 103.52 Mn |
| Sep 30, 2025 | 104.33 Mn |
| Jun 30, 2025 | 108.96 Mn |
| Mar 31, 2025 | 104.37 Mn |
| Dec 31, 2024 | 98.24 Mn |
| Sep 30, 2024 | 55.20 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Mar 31, 2024 | 13.07 Mn |
| Dec 31, 2023 | 11.79 Mn |
| Sep 30, 2023 | 12.97 Mn |
| Jun 30, 2023 | 14.66 Mn |
| Mar 31, 2023 | 9.34 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Sep 30, 2022 | 6.55 Mn |
| Jun 30, 2022 | 6.05 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 7.45 Mn |
| Sep 30, 2021 | 5.90 Mn |